ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,783 | -52.5% | 1,692,053 | -33.3% | 0.01% | -45.8% |
| Q2 2023 | $16,386 | -22.7% | 2,536,603 | -9.8% | 0.02% | -14.3% |
| Q1 2023 | $21,199 | -1.4% | 2,811,503 | +32.5% | 0.03% | -3.4% |
| Q4 2022 | $21,500 | -99.9% | 2,122,403 | -28.8% | 0.03% | -31.0% |
| Q3 2022 | $29,480,000 | -31.4% | 2,980,803 | -26.2% | 0.04% | -17.6% |
| Q2 2022 | $42,987,000 | +68.4% | 4,036,303 | +54.2% | 0.05% | +70.0% |
| Q1 2022 | $25,522,000 | +231.0% | 2,617,603 | +385.5% | 0.03% | +200.0% |
| Q4 2021 | $7,711,000 | +356.5% | 539,203 | +539.6% | 0.01% | +400.0% |
| Q3 2021 | $1,689,000 | -81.0% | 84,300 | -79.1% | 0.00% | -81.8% |
| Q2 2021 | $8,870,000 | – | 403,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |